The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
The new facility marks a significant milestone for Fredun Pharmaceuticals as it expands its footprint in the rapidly growing pet care industry in India
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
JB’s domestic business continued to out-perform the market with all our major brands posting strong growth
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
Stable profits, low leverage to keep credit profiles comfortable
Wanbury receives CEP approval from EDQM for launch of Dextromethorphan API
Innovative product offerings to capitalise on emerging opportunities within and beyond the sexual wellness market
Subscribe To Our Newsletter & Stay Updated
